Rishon Lezion, Israel

Yossef Klinger

This inventor holds 1 USPTO granted patent. Top assignee: Compugen Ltd. Corporation. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yossef Klinger. Retrieved from https://idiyas.com/inventor/yossef-klinger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yossef Klinger: Innovator in Bioactive Peptides

Introduction

Yossef Klinger is a notable inventor based in Rishon Lezion, Israel. He has made significant contributions to the field of biochemistry, particularly in the development of bioactive peptides. His work focuses on the therapeutic potential of these peptides in treating various disorders.

Latest Patents

Yossef Klinger holds a patent for "Bioactive peptides and methods of using same." This patent discloses peptide ligands for G-protein coupled receptors that are useful for treating disorders associated with G-protein coupled receptor activation. He has 1 patent to his name, showcasing his innovative approach to biopharmaceuticals.

Career Highlights

Klinger is currently employed at Compugen Ltd. Corporation, where he continues to advance research in the field of bioactive compounds. His work at Compugen has positioned him as a key player in the development of novel therapeutic strategies.

Collaborations

Throughout his career, Yossef Klinger has collaborated with talented individuals such as Ronen Shemesh and Zurit Levine. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Yossef Klinger is a distinguished inventor whose work in bioactive peptides has the potential to impact the treatment of various disorders. His contributions to the field are noteworthy, and his ongoing research promises to yield further advancements in biopharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…